GlaxoSmithKline

GlaxoSmithKline

GlaxoSmithKline (GSK)GlaxoSmithKline - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For more information, visit www.gsk.com.

GlaxoSmithKline RSS Channel

Filters
List of articles in category GlaxoSmithKline
Title Published Date
GlaxoSmithKline receives EU approval for a new therapeutic indication for Arixtra® 01 October 2010
GSK regulatory update on Avandia following EMA and FDA reviews 27 September 2010
BBC Panorama: "A Risk Worth Taking?" Programme. GlaxoSmithKline Right of Reply Statement 07 September 2010
Reports of narcolepsy in Europe following vaccination with Pandemrix™ 06 September 2010
GSK European Commission amends licence for Cervarix® 25 August 2010
GSK receives CHMP positive opinion for a new indication for Arixtra 26 July 2010
GSK EU regulatory update on Avandia (rosiglitazone) 12 July 2010
GlaxoSmithKline enters agreement with Medivir for exclusive rights to cold sore treatment Xerclear™ 24 June 2010
GlaxoSmithKline receives conditional marketing authorisation in the EU for Arzerra® (ofatumumab) 21 April 2010
Updated GlaxoSmithKline statement on European regulatory guidance relating to manufacture of Rotarix 29 March 2010
GlaxoSmithKline announces Swiss approval of Duodart® 25 March 2010
GSK receives positive opinions in Europe for Tyverb® and Votrient™ 22 February 2010
Government orders for pandemic H1N1 vaccine 13 January 2010
Revolade (eltrombopag) receives positive opinion in Europe for chronic immune thrombocytopenic purpura 22 December 2009
GSK initiates second pivotal Phase III trial for investigational cardiovascular medication Darapladib 11 December 2009
GSK signs agreement with the WHO to donate 50 million doses of pandemic H1N1 vaccine 12 November 2009
Experience of GSK's H1N1 adjuvanted vaccine, Pandemrix™, and preliminary paediatric results 26 October 2009
Results from second clinical trial of GSK's H1N1 adjuvanted vaccine confirm immune response and tolerability 21 October 2009
GSK partners with UK Government and Wellcome Trust to stimulate innovation 15 October 2009
Initial results from first clinical trial of GSK's H1N1 adjuvanted vaccine 14 September 2009